3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Stimulation of Caveolin-1 Signaling Improves Arteriovenous Fistula Patency

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective:

          Arteriovenous fistulae (AVF) are the most common access created for hemodialysis; however, many AVF fail to mature and require repeated intervention, suggesting a need to improve AVF maturation. Eph-B4 is the embryonic venous determinant that is functional in adult veins and can regulate AVF maturation. Caveolin-1 (Cav-1) is the major scaffolding protein of caveolae, a distinct microdomain that serves as a mechanosensor at the endothelial cell membrane. We hypothesized that Cav-1 function is critical for Eph-B4-mediated AVF maturation.

          Approach and Results:

          In a mouse aortocaval fistula model, both Cav-1 mRNA and protein were increased in the AVF compared to control veins. Cav-1 KO mice showed increased fistula wall thickening (p=0.0005) and outward remodeling (p<0.0001), with increased eNOS activity compared with WT mice. Ephrin-B2/Fc inhibited AVF outward remodeling in WT mice but not in Cav-1 KO mice, and was maintained in Cav-1 endothelial reconstituted (RC) mice (WT, p=0.0001; Cav-1 KO, p=0.7552; Cav-1 RC, p=0.0002). Cavtratin, a Cav-1 scaffolding domain peptide, decreased AVF wall thickness in WT mice as well as in Eph-B4 het mice compared to vehicle alone (WT, p=0.0235; Eph-B4 het, p=0.0431); cavtratin also increased AVF patency (day 42) in WT mice (p=0.0275).

          Conclusions:

          Endothelial Cav-1 mediates Eph-B4-mediated AVF maturation. The Eph-B4-Cav-1 axis regulates adaptive remodeling during venous adaptation to the fistula environment. Manipulation of Cav-1 function may be a translational strategy to enhance AVF patency.

          Graphical Abstract

          Related collections

          Author and article information

          Journal
          9505803
          8623
          Arterioscler Thromb Vasc Biol
          Arterioscler. Thromb. Vasc. Biol.
          Arteriosclerosis, thrombosis, and vascular biology
          1079-5642
          1524-4636
          13 February 2019
          April 2019
          01 April 2020
          : 39
          : 4
          : 754-764
          Affiliations
          [1 ]Vascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT, USA.
          [2 ]Department of Surgery, Yale School of Medicine, New Haven, CT, USA.
          [3 ]Department of Surgery, VA Connecticut Healthcare System, West Haven, CT, USA.
          [4 ]Department of Vascular Surgery, The University of Tokyo, Tokyo, Japan.
          [5 ]Department of Pharmacology, Yale School of Medicine, New Haven, CT, USA
          Author notes
          Correspondence: Alan Dardik, Yale University School of Medicine, 10 Amistad Street, Room 437, PO Box 208089, New Haven, CT 06520-8089 USA. Tel: 203-737-2082. ORCID: orcid.org/0000-0001-5022-7367, alan.dardik@ 123456yale.edu
          [*]

          These authors contributed equally to this article

          Article
          PMC6436985 PMC6436985 6436985 nihpa1521484
          10.1161/ATVBAHA.119.312417
          6436985
          30786746
          92637444-8e06-40a5-8339-c7db7208d884
          History
          Categories
          Article

          Animal Models of Human Disease,Eph-B4,mice,eNOS,Basic Science Research,caveolin-1,vein,Vascular Biology,Arteriovenous fistula

          Comments

          Comment on this article